4llz
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | + | {{STRUCTURE_4llz| PDB=4llz | SCENE= }} | |
| + | ===Crystal structure of lumiracoxib bound to the apo-mouse-cyclooxygenase-2=== | ||
| + | {{ABSTRACT_PUBMED_24060487}} | ||
| - | + | ==Function== | |
| + | [[http://www.uniprot.org/uniprot/PGH2_MOUSE PGH2_MOUSE]] Mediates the formation of prostaglandins from arachidonate. May have a role as a major mediator of inflammation and/or a role for prostanoid signaling in activity-dependent plasticity.<ref>PMID:12925531</ref> <ref>PMID:20463020</ref> <ref>PMID:20810665</ref> <ref>PMID:21489986</ref> | ||
| - | + | ==About this Structure== | |
| + | [[4llz]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4LLZ OCA]. | ||
| - | + | ==Reference== | |
| + | <ref group="xtra">PMID:024060487</ref><references group="xtra"/><references/> | ||
| + | [[Category: Mus musculus]] | ||
| + | [[Category: Prostaglandin-endoperoxide synthase]] | ||
| + | [[Category: Banerjee, S.]] | ||
| + | [[Category: Marnett, L J.]] | ||
| + | [[Category: Windsor, M A.]] | ||
| + | [[Category: Xu, S.]] | ||
| + | [[Category: Cox-2]] | ||
| + | [[Category: Cycloooxygenase]] | ||
| + | [[Category: Diooxygenase]] | ||
| + | [[Category: Glycosylation]] | ||
| + | [[Category: Lumiracoxib]] | ||
| + | [[Category: Membrane]] | ||
| + | [[Category: Oxidoreductase-oxidoreductase inhibitor complex]] | ||
| + | [[Category: Peroxidase]] | ||
| + | [[Category: Prostaglandin g/h synthase 2]] | ||
| + | [[Category: Prostaglandin-endoperoxide synthase]] | ||
Revision as of 08:02, 16 October 2013
Contents |
Crystal structure of lumiracoxib bound to the apo-mouse-cyclooxygenase-2
Template:ABSTRACT PUBMED 24060487
Function
[PGH2_MOUSE] Mediates the formation of prostaglandins from arachidonate. May have a role as a major mediator of inflammation and/or a role for prostanoid signaling in activity-dependent plasticity.[1] [2] [3] [4]
About this Structure
4llz is a 2 chain structure with sequence from Mus musculus. Full crystallographic information is available from OCA.
Reference
- Windsor MA, Valk PL, Xu S, Banerjee S, Marnett LJ. Exploring the molecular determinants of substrate-selective inhibition of cyclooxygenase-2 by lumiracoxib. Bioorg Med Chem Lett. 2013 Nov 1;23(21):5860-5864. doi:, 10.1016/j.bmcl.2013.08.097. Epub 2013 Sep 6. PMID:24060487 doi:http://dx.doi.org/10.1016/j.bmcl.2013.08.097
- ↑ Rowlinson SW, Kiefer JR, Prusakiewicz JJ, Pawlitz JL, Kozak KR, Kalgutkar AS, Stallings WC, Kurumbail RG, Marnett LJ. A novel mechanism of cyclooxygenase-2 inhibition involving interactions with Ser-530 and Tyr-385. J Biol Chem. 2003 Nov 14;278(46):45763-9. Epub 2003 Aug 18. PMID:12925531 doi:http://dx.doi.org/10.1074/jbc.M305481200
- ↑ Vecchio AJ, Simmons DM, Malkowski MG. Structural basis of fatty acid substrate binding to cyclooxygenase-2. J Biol Chem. 2010 Jul 16;285(29):22152-63. Epub 2010 May 12. PMID:20463020 doi:10.1074/jbc.M110.119867
- ↑ Duggan KC, Walters MJ, Musee J, Harp JM, Kiefer JR, Oates JA, Marnett LJ. Molecular basis for cyclooxygenase inhibition by the non-steroidal anti-inflammatory drug naproxen. J Biol Chem. 2010 Nov 5;285(45):34950-9. Epub 2010 Sep 1. PMID:20810665 doi:10.1074/jbc.M110.162982
- ↑ Vecchio AJ, Malkowski MG. The structural basis of endocannabinoid oxygenation by cyclooxygenase-2. J Biol Chem. 2011 Jun 10;286(23):20736-45. Epub 2011 Apr 13. PMID:21489986 doi:10.1074/jbc.M111.230367
